Related by context. All words. (Click for frequent words.) 71 breast cancer genes BRCA1 70 BRCA2 mutations 70 BRCA2 carriers 69 mutated BRCA1 69 BRCA2 mutation 69 BRCA2 gene mutation 67 BRCA2 gene 66 genes BRCA1 66 BRCA1 mutations 65 BRCA2 genes 65 BRCA mutation 64 inherited mutations 63 BRCA2 63 TGFBR1 * 6A 63 testicular germ cell 63 BRCA genes 63 BRAC2 63 Li Fraumeni 62 gene BRCA2 62 breast cancer gene mutation 62 BRCA1 gene 62 BRCA mutations 62 hereditary breast cancer 61 prostate pancreatic 61 BRCA1 BRCA2 61 BRCA gene mutation 61 BRCA2 mutation carriers 61 BARD1 61 precursor lesions 61 BRCA1 gene mutation 61 germline mutations 61 Genetic variants 61 uterine ovarian 60 HG PIN 60 BRCA1 60 CYP#D# gene 60 atypical hyperplasia 60 MLL2 59 endometrial cancers 59 CDH1 59 BRIP1 59 ovarian cancers 59 PALB2 59 hypermethylated 59 KRAS oncogene 59 gynecologic malignancy 59 ovarian pancreatic 59 BRCA1 mutation 59 Epstein Barr virus EBV 59 TCF#L# gene 59 lung adenocarcinoma 58 FGFR2 58 p# mutations 58 promoter hypermethylation 58 anal cancers 58 apolipoprotein E4 58 BRCA2 breast cancer 58 p# mutation 58 genetic aberrations 58 mtDNA mutations 58 hereditary predisposition 58 TACI mutations 58 narcolepsy cataplexy 58 chromosomal abnormalities 58 somatic mutations 58 gene mutations 58 PIK3CA 58 Ovary removal 58 MSH2 58 APOE ε4 58 familial pancreatic cancer 57 chlamydial infection 57 colorectal cancer CRC 57 PARP inhibition 57 BRCA mutation carriers 57 MLH1 57 MYCN amplification 57 TP# gene 57 GPC5 57 genetic abnormalities 57 epigenetic changes 57 Colon polyps 57 inherited predisposition 57 MTHFR 57 herpesviruses 57 chromosomal defects 57 benign proliferative breast 57 Telomere length 57 genes BRCA 57 breast endometrial 57 PTEN mutations 57 ZNF# 56 Genetic variations 56 #q# deletion 56 mutated genes 56 abnormal methylation 56 cause cardiac channelopathies 56 neuroblastomas 56 FMR1 gene 56 microdeletions 56 gene fusions 56 Human papillomavirus 56 aneuploidy 56 susceptibility genes 56 JAK2 mutation 56 cervical breast 56 atypia 56 clade B 56 susceptibility gene 56 lobular carcinoma 56 genital tract infections 56 Genital HPV 56 CDKN2A 56 PTPN# 56 breast uterine 56 poorer prognosis 56 genetic variants associated 56 Fragile X gene 56 breast cancer susceptibility genes 56 aneuploidies 56 squamous cell lung cancer 56 nonmelanoma skin cancers 56 Li Fraumeni syndrome 56 LRP5 56 endometrial ovarian 56 chromosomal disorders 56 coinfection 56 familial predisposition 56 BRCA1 mutation carriers 56 KRAS mutations 56 CHEK2 56 faulty BRCA genes 56 causal variants 56 TCF#L# 55 IDH mutations 55 HNPCC 55 prostate cancer CaP 55 genetic mutations 55 hormone receptor negative 55 maternally inherited 55 Basal cell 55 MYH9 gene 55 colorectal tumors 55 obstructive coronary artery 55 ARID1A 55 CCR5 delta# 55 APOE e4 55 TP# mutation 55 chromosomal rearrangement 55 ovarian breast 55 chromosomal instability 55 LRRK2 gene 55 gastric carcinoma 55 genetic loci 55 prognostic markers 55 deCODE BreastCancer TM 55 hereditary breast 55 ApoE4 gene 55 molecular abnormalities 55 HPV genotypes 55 Genetic mutations 55 neuroblastoma tumors 55 ovarian endometrial 55 frequently benign tumor 55 sCJD 55 epigenetic modification 55 genetic polymorphisms 55 heritable genetic 55 Tay Sachs thalassemia 55 INF2 55 mutations 55 chromosomal anomalies 55 lobular breast cancer 55 HPV vaccine protects 55 promoter methylation 55 Epidemiologic studies 55 diagnostic biomarker 55 FGFR2 gene 55 MGUS 55 N. gonorrhoeae 55 diffuse gastric 55 modifier genes 55 nodal metastasis 55 papillomaviruses 55 ERBB2 54 TP# mutations 54 ovarian uterine 54 HER2 overexpression 54 APOL1 54 HNSCC 54 KRAS BRAF 54 anovulatory infertility 54 endometrial carcinoma 54 nonhereditary 54 lymph node biopsies 54 K ras mutations 54 NR#A# gene 54 telomere lengths 54 epithelial tumors 54 impair fertility 54 ovarian cervical 54 tumor subtypes 54 polyps growths 54 invasive carcinoma 54 de novo mutations 54 adenomatous polyps 54 HPV# 54 renal cell carcinomas 54 Colorectal cancer CRC 54 lung cancer NSCLC 54 BRAF gene 54 underarm lymph nodes 54 methylation markers 54 vaginal cancers 54 node metastases 54 ductal breast cancer 54 V Leiden 54 causative mutations 54 JAK2 enzyme 54 skeletal metastases 54 TMEM#B 54 IgA deficiency 54 faulty BRCA2 gene 54 invasive cervical cancer 54 PTEN gene 54 bladder cancers 54 HbF 54 ALK gene 54 BRAF mutation 54 colorectal neoplasia 54 molecular subtypes 54 BRCA gene mutations 54 leukaemias 54 chromosomal regions 54 operable breast cancer 54 mammary stem cells 54 invasive lobular 54 sarcosine 54 molecular biomarkers 54 precancerous tumors 54 Yamanaka recipe 54 CGG repeats 54 LPA gene 54 hypermethylation 54 Menopausal hormone therapy 54 APOE genotype 54 precancerous cervical 54 splice junctions 54 commonly mutated genes 54 gene rearrangements 54 denser breasts 54 pancreatic lung 54 mitochondrial DNA mtDNA 53 Human papillomavirus HPV 53 recessive mutations 53 genomic variants 53 spontaneous mutations 53 cervical neoplasia 53 BRAF V#E mutation 53 rs# [001] 53 causes genital warts 53 thrombophilia 53 M. genitalium 53 KIAA# 53 penile anal 53 genetic syndromes 53 mammary cancers 53 genetic makeups 53 apolipoprotein E gene 53 STAT4 53 oligodendrogliomas 53 dysplastic lesions caused 53 monogenic 53 micro RNAs 53 ApoE4 53 breast cancer metastasis 53 DNA methylation patterns 53 IL#R 53 axillary lymph nodes 53 cervical carcinoma 53 ALK mutations 53 ABCB1 53 breast ovarian 53 druggable targets 53 oropharyngeal cancer 53 Chlamydia trachomatis infection 53 HER2 receptor 53 Stat5 53 Male infertility 53 paternal lineages 53 KIF6 gene 53 ARF1 53 susceptibility loci 53 breast cancer subtypes 53 APOE4 53 kidney urologic 53 prostate adenocarcinoma 53 epigenetic regulation 53 KCNQ1 53 mutated BRAF gene 53 serous ovarian cancer 53 intestinal polyps 53 gestational diabetes mellitus 53 spontaneous preterm delivery 53 GBA mutations 53 HER2 positive cancers 53 VKORC1 53 monozygotic twins 53 colorectal lung 53 leiomyomas 53 cirrhosis liver failure 53 missense mutations 53 neuroligins 53 nonvaccine 53 risk HPV genotypes 53 Epstein Barr Virus EBV 53 GBV C 53 C#Y 53 IKZF1 53 diagnostic biomarkers 53 haematopoietic 53 curable cancers 53 penile cancers 53 tumor suppressor protein 53 PCa 53 BRCA deficient 53 human papillomaviruses HPV 53 HER2 neu 53 deCODE ProstateCancer TM 53 chromosome translocations 53 Trichomonas vaginalis 53 virulence genes 53 ovarian tumors 53 SMAD4 53 precancerous cervical lesions 53 epigenetic alterations 53 UGT#B# 53 Leydig cells 53 anal HPV 53 Chlamydia infection 53 Zinc deficiency 53 GISTs 53 C. trachomatis 53 malignant transformation 53 Genetic predisposition 53 GSTP1 53 chromosomal alterations 53 familial clustering 53 cervical lesions 53 fibrocystic disease 53 uterine cancers 53 chromosome aberrations 53 chromosomal anomaly 53 SE alleles 53 Prostatitis 53 mammary cells 53 vaginal lesions 53 pre cancerous polyps 53 HLA DQ2 53 estrogen receptor negative 53 pneumococci 53 SORL1 53 ovarian lung 53 prion infection 53 autism susceptibility genes 53 microvascular disease 53 gene mutation 53 mutated BRCA 53 fluoroquinolone resistance 53 ductal cancer 53 GSTT1 53 colon tumors 52 BRCA carriers 52 HPVs 52 allelic variants 52 malignant prostate 52 gallstone disease 52 colorectal cancers 52 severe congenital neutropenia 52 HGPS 52 prostate cancers 52 gene locus 52 Uterine fibroids 52 folate metabolism 52 Thyroid nodules 52 sickle cell cystic fibrosis 52 genes CYP#C# 52 mutation 52 genomic rearrangement 52 CALHM1 52 transthyretin 52 granzyme B 52 abnormal growths 52 benign polyps 52 bisulfite sequencing 52 Cryptococcus neoformans 52 DNA rearrangements 52 EGFR mutation status 52 prostate carcinoma 52 GNAQ 52 elevated CRP 52 spontaneous mutation 52 cervical intraepithelial neoplasia 52 gastric cancers 52 methylated DNA 52 SCN5A 52 p#INK#a 52 genital HPV infections 52 lobular 52 nucleus Chinnery 52 anal lesions 52 deCODE BreastCancer 52 Metastases 52 testicular cancers 52 ORMDL3 52 SORL1 gene 52 blood clotting disorders 52 conserved sequences 52 Hurthle cell 52 BRCA 52 Imprinted genes 52 M. pneumoniae 52 LQTS 52 asymptomatic carriers 52 germline mutation 52 Malignant tumors 52 BMPR2 52 abnormal pap smears 52 MEF2A 52 FGFs 52 chromosomally normal 52 uveal melanoma 52 Uterine cancer 52 estrogen receptors 52 Cytogenetic 52 causative genes 52 LHRH receptor positive 52 beta1 integrin 52 TOMM# 52 hormonally sensitive 52 mammary duct 52 Froguel 52 non coding RNA 52 chlamydial infections 52 cerebral microbleeds 52 deleterious mutation 52 fetal chromosomal 52 basal cell nevus syndrome 52 gene predisposing 52 Multidrug resistant 52 MC1R 52 PCA3 gene 52 prostate carcinogenesis 52 Squamous cell 52 chlamydial 52 endogenous estrogen 52 Hair follicle 52 Aneuploidy 52 epithelial tissues 52 chromosomal aberrations 52 elevated triglyceride levels 52 paternally inherited 52 TSC1 52 Y STR 52 OnDose TM 52 neoplasias 52 LIS1 52 mosaicism 52 subclinical hyperthyroidism 52 diagnosed prenatally 52 non mutated KRAS 52 mutated K ras 52 microdeletion 52 muscular dystrophy cystic fibrosis 52 EGFR protein 52 CpG island 52 FLT3 52 MTHFR gene 52 pancreatic adenocarcinoma 52 Pancreatic neuroendocrine tumors 52 T. vaginalis 52 breast cancer gene mutations 52 MiRNAs 52 breast carcinomas 52 genetic alterations 52 undescended testes 52 lung adenocarcinomas 52 grade cervical dysplasia 52 Anopheles gambiae mosquitoes 52 LungAlert TM 52 pre malignant lesions 52 shortened telomeres 52 recessive genetic 52 NNRTI resistance 52 PICALM 52 activating mutations 52 gene variants 52 lymphomas leukemias 52 APOE allele 52 placental malaria 52 precancers 52 CFTR gene 52 Meckel Gruber 52 mammary tumors 52 Leukemias 52 sequence homology 52 Tr DNA 52 GATA4 51 Polymorphisms 51 etiologic 51 neuroendocrine cancers 51 medulloblastomas 51 malignant ovarian 51 DNA methyltransferases 51 ALK inhibitors 51 breast pancreatic 51 HLA DRB1 51 oncogenic HPV 51 SPINK1 51 granulosa cell 51 genes predisposing 51 susceptibility alleles 51 EGFR mutations 51 Squamous 51 HMMR 51 HER2 gene 51 faulty BRCA1 gene 51 clefting 51 grade serous ovarian 51 Treg cell 51 IDH1 51 gamma globin gene 51 sentinel lymph node biopsy 51 chromosome #q# [001] 51 abnormal chromosomes 51 densest breasts 51 hereditary hemochromatosis 51 familial adenomatous polyposis 51 cervical precancers 51 Chlamydia trachomatis 51 STK# [002] 51 genotoxic stress 51 adenocarcinomas 51 Single Nucleotide Polymorphisms SNPs 51 prognostic biomarkers 51 genetically mapped 51 postmenopausal breast cancer 51 Rh incompatibility 51 prostate ovarian 51 Clusterin 51 MC1R gene 51 premenopausal breast cancer 51 dopamine D4 receptor 51 HER2 expression 51 progranulin gene 51 armpit lymph nodes 51 premutation 51 Chlamydia psittaci 51 basal cell carcinoma BCC 51 environmental toxicants 51 VHL gene 51 GAB2 51 Bone metastases 51 microcephalin 51 breast carcinoma 51 cisplatin resistant 51 HC2 test 51 lobular cancer 51 mutated gene 51 KRAS mutation 51 Chronic pancreatitis 51 endometrial hyperplasia 51 polycystic ovarian syndrome PCOS 51 ADPKD 51 filoviruses 51 EGFR mutation 51 FUS protein 51 CETP VV 51 MassARRAY ® 51 dependent neoplasia 51 genetic biomarkers 51 Breast Ovarian Cancer 51 APOE gene 51 hereditary nonpolyposis colorectal cancer 51 bioluminescent imaging 51 G6PD deficiency 51 microRNA expression 51 cardiac channelopathies 51 benign growths 51 familial ALS 51 autosomal recessive 51 metastatic prostate 51 genital herpes infections 51 chromosomal rearrangements 51 WDR# 51 miRNA genes 51 pathogenic mutations 51 ABCB1 gene 51 abnormal glucose metabolism 51 KRAS variant 51 recurrent miscarriages 51 microsatellite instability 51 microchimerism 51 pituitary adenomas 51 myeloproliferative disorders 51 chromosomal aberration 51 genomic rearrangements 51 Endometrial cancer 51 Systemic lupus erythematosus 51 estrogen receptor ER 51 distal colon cancer 51 #q# [001] 51 Cervista HPV 51 APOE e4 gene 51 advanced neoplasia 51 myelofibrosis polycythemia vera 51 polycystic ovary syndrome PCOS 51 situ LCIS 51 NF1 gene 51 blastomere 51 trypanosomes 51 thyrotropin levels 51 androgen receptor gene 51 penetrance 51 Genetic variation 51 parkin gene 51 JAK2 gene 51 histone modifications 51 thrombo embolic 51 DQB1 * 51 MC4R gene 51 TT genotype 51 postoperative delirium 51 CDK4 51 pharmacogenetic tests 51 ADDLs 51 Human Papilloma Virus 51 non anthracycline Taxotere 51 CIN2 + 51 pheochromocytomas 51 hepatocellular carcinomas 51 epigenetic modifications 51 autosomal dominant inheritance 51 Hashimoto thyroiditis 51 CCL#L# 51 Beta thalassemia 51 LMNA 51 genetic variant 51 Leydig cell 51 invasive ductal breast cancer 51 taxane therapy 51 human leukocyte antigens 51 BRAF V#E 51 Six3 51 estrogen receptor positive 51 Folate deficiency 51 FMRP protein 51 vimentin 51 ovarian hormones 51 colorectal polyps 51 SRY gene 51 chromosome abnormalities 51 contralateral breast cancer 51 Human papilloma virus 51 prostate colon 51 oral squamous cell 51 neoplasia 51 Antibiotic resistant infections 51 Adjuvant chemotherapy 51 androgen receptor AR 51 epigenetic mechanisms 51 abnormal pap 51 immuno compromised individuals 51 lung pancreatic 51 latent tuberculosis infection 51 HLA markers 51 candidate alferminogene tadenovec 51 antinuclear antibodies 51 tumor suppressors cytokines 51 HOTAIR 51 #q#.# deletion syndrome 51 ubiquitinated 51 thalassemia sickle cell 51 Notch receptors 51 FGFR1 50 familial hypercholesterolemia 50 subclinical atherosclerosis 50 sporadic ALS 50 nucleotide substitutions 50 medulloblastoma tumors 50 lobular involution 50 microscopic colitis 50 hyper IgE syndrome 50 shorter telomeres 50 HPV infections 50 Melanomas 50 Gastric cancer 50 antigen PSA 50 tumor suppressor gene 50 colorectal gastric 50 advanced adenomas 50 chromosomal defect 50 UGT#A# 50 atypical ductal hyperplasia 50 cyclin E 50 immunocompromised individuals 50 breast cancers 50 Affibody ® molecules 50 mammographic density 50 colon polyps 50 FGFR3 50 meningiomas 50 Sporadic CJD 50 MLL gene 50 abnormal Pap test 50 TNF blocker therapy 50 peptide antigens 50 advanced adenoma 50 vitro assay 50 lung carcinomas 50 Activating mutations 50 mitochondrial mutations 50 virulence determinants 50 intracellular pathogens 50 tadenovec Ad5FGF 4 50 APOE4 gene 50 Salmonella Typhi 50 VIPR2 50 Listeria infections 50 gastric adenocarcinoma 50 murine leukemia virus 50 epithelial cancers 50 genomic alterations 50 uterine cervix 50 premature menopause 50 Wnt signaling pathway 50 bowel cancers 50 Darapladib 50 cystic fibrosis Duchenne muscular 50 transfusion syndrome 50 Cowden syndrome 50 benign breast 50 deafness neurological 50 Mitochondrial DNA 50 OGG1 50 apoE 50 overexpress HER2 50 endocrine therapies 50 aneuploid cells 50 tumor suppressors 50 KIT mutations 50 CYP#C# [001] 50 inherited gene mutation 50 reproductive abnormalities 50 chlamydia trachomatis 50 Androgen deprivation therapy 50 Kufs disease 50 ApoE4 allele 50 cervical vaginal 50 ovarian colorectal 50 myeloproliferative neoplasms MPNs 50 glucose abnormalities 50 phenotypic variation 50 primary cilia 50 CMV infection 50 infectious prion proteins 50 HOX genes 50 ductal carcinomas 50 thyroid nodules 50 hepatitis B infection 50 myopathies 50 metastatic bladder 50 prion strains 50 alferminogene tadenovec 50 MAPK pathway 50 Polymorphic Ventricular Tachycardia CPVT 50 seminoma 50 plasma lipid 50 slow metabolizers 50 somatic mutation 50 premalignant 50 colorectal carcinoma 50 basal cell 50 RUNX3 50 noncoding RNAs 50 mitochondrial toxicity 50 rs# [002] 50 Cholangiocarcinoma 50 RNA viruses 50 Candida species 50 CNTNAP2 50 #q#.# [001] 50 prostate specific 50 Human Papillomavirus 50 Rh factor 50 pilocytic astrocytomas 50 pituitary tumors 50 neurofibromas 50 Nonalcoholic fatty liver 50 Neurological disorders 50 preventive mastectomies 50 abnormal mammograms 50 Carcinoid tumors 50 BCR ABL protein 50 latent tuberculosis TB 50 proto oncogene 50 recurrent miscarriage 50 Trichomonas 50 colorectal bowel 50 dizygotic twins 50 chlamydia sexually transmitted 50 beta catenin protein 50 thyroid hormone levels 50 cancers 50 mitochondrial disorders 50 miRNA profiling 50 prognostic indicator 50 epithelial ovarian 50 endostatin 50 treating sarcoma testicular 50 endocrine tumors 50 ASCUS 50 potentially pathogenic microorganisms 50 Buyyounouski 50 E#F# 50 HPV 50 G allele 50 histone acetylation 50 nonmelanoma skin cancer 50 trastuzumab resistant 50 metastatic lesions 50 Human Papilloma Virus HPV 50 hereditary pancreatitis 50 HGPIN 50 recurrent ovarian 50 CHI#L# 50 IgG antibody 50 methylation profiling 50 spontaneous preterm birth 50 gene loci 50 deCODE AF TM 50 deleterious mutations 50 HER2 positive breast 50 VEGF expression 50 sexually transmitted HPV 50 allele frequencies 50 infective agent 50 untreated celiac disease 50 histone deacetylases 50 cervical uterine 50 EGF receptors 50 precancer 50 ApoE gene 50 breast tumors 50 Brain metastases 50 TCF4 50 filaggrin gene 50 dopamine receptor gene 50 XMRV infection 50 sporadic Creutzfeldt Jakob 50 Estrogen receptor positive 50 Folic acid supplements 50 nonnucleoside reverse transcriptase inhibitors 50 human papilloma viruses 50 genetic susceptibility 50 Gardasil protects 50 serogroup B 50 generalized vitiligo 50 APOE epsilon 4 50 tumor biopsies 50 SNP rs# [001] 50 NPM1 50 K ras gene 50 STK# gene 50 systemic scleroderma 50 postmenopausal hormone 50 malignant neoplasm 50 intrauterine infection 50 BRCA gene 50 LVNC 50 squamous cell skin 50 Kaposi sarcoma 50 glucocorticoid receptors 50 NFKBIA 50 mutant p# 50 Vitamin D insufficiency 50 renal carcinoma 50 malignant polyps 50 genetic manipulations 50 epigenetic markers 50 insulin resistance syndrome 50 fetal aneuploidy 50 simplex virus 50 monozygotic twin 50 adenomatous polyp 50 KIF6 gene variant 50 abnormal Pap smears 50 non syndromic 50 cervical HPV 50 Recurrences 50 spontaneous miscarriages 50 cell nuclei 50 anal penile 50 estrogen receptor 50 TMPRSS2 ERG fusion 50 urethritis 50 micrometastases 50 oesophageal adenocarcinoma 49 antisense therapies 49 C. pneumoniae 49 Human papillomaviruses 49 Oncogenes 49 Fatty liver 49 birth defects miscarriages 49 Genetic profiling 49 genetic variants 49 mammographically 49 precancerous colon polyps 49 periodontal infections 49 PGDH 49 heterozygote 49 K#R [002] 49 uterine tumors 49 #p# [001] 49 virus XMRV 49 HBV infection 49 ectopic pregnancies 49 prognostic marker 49 anaplastic lymphoma kinase 49 abnormal cytology 49 castration resistant 49 KCNE2 49 polycystic ovary syndrome 49 Peutz Jeghers syndrome 49 histological subtype 49 GBM tumors 49 mutant alleles 49 neoplastic 49 Celiac sprue 49 NF kB pathway 49 CYP#C# [002] 49 Chlamydia pneumoniae 49 axillary nodes 49 genital human papillomavirus 49 undergone hysterectomy 49 CHD7 49 colorectal adenomas 49 HPV subtypes 49 Pap smear screening 49 Stuttering tends 49 aberrant methylation 49 bacterium Neisseria meningitidis 49 malignant melanomas 49 methylation patterns 49 genetic determinants 49 paraganglioma 49 ataxias 49 Apobec3 49 vulvar cancers 49 miRNA molecules 49 NKX#.# 49 squamous cell cancers 49 Ebola Hemorrhagic Fever 49 behavioral disinhibition 49 DEC2 49 salpingo oophorectomy 49 Neisseria gonorrhoeae 49 Babesia 49 testicular tumors 49 EBV infection 49 pathogenic mechanisms 49 chromosomal deletions 49 ncRNAs 49 Genital herpes 49 DRD2 gene 49 Gliomas 49 progesterone receptor negative 49 lobular carcinomas 49 MYH9 49 Helicobacter 49 genital ulcer disease 49 von Hippel Lindau 49 Circulating tumor cells 49 SOD1 gene 49 Opportunistic infections 49 EGFR gene 49 gene APOE4 49 aneuploid 49 HFE gene 49 transgenic rats 49 Epidermal Growth Factor Receptor 49 trichomonas 49 multigene 49 SLITRK1 49 periodontal bacteria 49 oxidized phospholipids 49 pancreatic cancers 49 leukodystrophies 49 EphB2